APA (7th ed.) Citation

Marchioni, M., Kriegmair, M., Heck, M., Amiel, T., Porpiglia, F., Ceccucci, E., . . . Mir, M. C. (2021). Development of a novel risk score to select the optimal candidate for cytoreductive nephrectomy among patients with metastatic renal cell carcinoma: Results from a multi-institutional registry (REMARCC). European urology oncology, 4(2), . https://doi.org/10.1016/j.euo.2020.12.010

Chicago Style (17th ed.) Citation

Marchioni, Michele, et al. "Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma: Results from a Multi-institutional Registry (REMARCC)." European Urology Oncology 4, no. 2 (2021). https://doi.org/10.1016/j.euo.2020.12.010.

MLA (9th ed.) Citation

Marchioni, Michele, et al. "Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma: Results from a Multi-institutional Registry (REMARCC)." European Urology Oncology, vol. 4, no. 2, 2021, https://doi.org/10.1016/j.euo.2020.12.010.